Tri Femynor Kit
Product Images NDC 69238-1607

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tri Femynor (NDC 69238-1607). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Ny Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Blister For Pi (Tri Femynor 1)

An instructional diagram for Tri Femynor oral contraceptive tablets showing a weekly pill-taking schedule from Sunday to Saturday. It features color-coded circles for each day over four weeks, with arrows indicating the direction to take pills from left to right. Instructions for Sunday starters and day 1 starters are included, along with storage and handling advice.*

FDA Label Image

Norgestimate Chem Struc (Tri Femynor 2)

Chemical structure of norgestimate, the active ingredient in Tri Femynor, shown as a steroidal molecular diagram with labeled functional groups.*

FDA Label Image

Ee Chem Struc (Tri Femynor 3)

Chemical structure of Ethinyl Estradiol, shown as a detailed skeletal formula highlighting ring structures and functional groups.*

FDA Label Image

Patient-info-figure (Tri Femynor 4)

A vertical effectiveness chart for contraception methods showing fewer pregnancies per 100 women per year at the top and more pregnancies at the bottom. Categories listed include highly effective methods (implants, injections, intrauterine devices, sterilization), birth control pills/skin patch/vaginal ring, barrier methods (condoms, diaphragm), less effective methods (no sex during fertile days, spermicide, withdrawal), and no birth control at the bottom.*

FDA Label Image

Blister-pic (Tri Femynor 5)

An instructional diagram for Tri Femynor (norgestimate and ethinyl estradiol tablets) showing the pill pack layout and usage directions. It illustrates the pill-taking order day-by-day from left to right for four weeks, with color-coded pills for each week. Instructions for Sunday starters and day 1 starters are provided, along with storage and handling information, and distributor and manufacturing details.*

FDA Label Image

Blister (Tri Femynor 6)

The image shows the medication guide label inside a Tri Femynor kit, containing norgestimate and ethinyl estradiol tablets. It outlines the 28-day dosing schedule with colored circles representing each week's tablets: pink for week 1, orange for week 2, red for week 3, and white for week 4. The label includes storage instructions to keep at 20° to 25°C (68° to 77°F) and to protect from light. It is distributed by Amneal Pharmaceuticals LLC and made in Germany.*

FDA Label Image

Carton (Tri Femynor 7)

Tri Femynor kit packaging label showing a human prescription drug with norgestimate and ethinyl estradiol tablets. The label indicates 1 blister pack containing 28 tablets with specified doses of 0.18 mg, 0.215 mg, and 0.25 mg norgestimate and 0.035 mg ethinyl estradiol in colored tablets. The labeler is Amneal Pharmaceuticals NY LLC with NDC 69238-1607. The packaging includes storage instructions and patient information highlights.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.